Claritas Pharmaceuticals is developing R-107, a nitric oxide-releasing molecule designed to treat vaccine-resistant COVID-19 infection.
Arthritis Knee Pain Centers
2 followers
Bristol-Myers Squibb
259 followers
NYU Langone Health
25 followers
West Pharmaceutical Services
8 followers
Curia Global
6 followers
AbbVie
276 followers
Navitus Health
4 followers
HistoSonics
3 followers
Xeris Pharmaceuticals
2 followers
Corcept Therapeutics
4 followers
Rocket Pharmaceuticals
3 followers
Explore companies